Jordy Johannes Eduardus Rovers
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jordy Johannes Eduardus Rovers has a total of 64 co-authors. Here are the top co-authors by number of shared publications:
Annemiek Dols
UMC Utrecht Brain Center, Department of Psychiatry, University Medical Center Utrecht, Utrecht, The Netherlands
3 shared publicationsIndira Tendolkar
Department of Psychiatry, Radboud University Nijmegen, Donders Institute for Brain, Cognition and Behavior, Nijmegen, the Netherlands
2 shared publicationsMetten Somers
UMC Utrecht Brain Center, Department of Psychiatry, University Medical Center Utrecht, Utrecht, The Netherlands
2 shared publicationsA. C. M. Vergouwen
Department of Psychiatry and Medical Psychology OLVG Hospital P.O. Box 95500 1090 HM Amsterdam The Netherlands
1 shared publicationA. Dols
Department of Psychiatry Amsterdam UMC, Location Vrije Universiteit Amsterdam Boelelaan 1117 Amsterdam The Netherlands
1 shared publicationA. J. C. Paarlberg
Canisius-Wilhelmina Hospital
1 shared publication
Latest Publications
- 1 June 2026
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 183 (6) , 401-408
A Global Delphi-Based Expert Consensus on Relapse Prevention Strategies Following Successful Electroconvulsive Therapy for Major Depressive Disorder
PsychiatryOnline.org is the platform for all American Psychiatric Association Publishing journals, DSM, and bestselling textbooks, as well as APA Practice Guidelines, and continuing medical education.
- 1 June 2026
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 183 (6) , 401-408
A Global Delphi-Based Expert Consensus on Relapse Prevention Strategies Following Successful Electroconvulsive Therapy for Major Depressive Disorder
PsychiatryOnline.org is the platform for all American Psychiatric Association Publishing journals, DSM, and bestselling textbooks, as well as APA Practice Guidelines, and continuing medical education.
- Open Access
- 18 February 2026
- Published by Frontiers Media SA in Frontiers in Psychiatry
- Vol. 17
Improving mental health through body-awareness with dynamic interpersonal therapy in patients with persistent somatic symptoms: an explorative cohort study
Introduction: This study explored the changes in mental health and body-awareness in patients with severe persistent somatic symptoms (PSS) treated with multidisciplinary Dynamic Interpersonal Therapy. Methods: In this longitudinal study 56 patients with severe somatic-symptom disorder (DSM-5) were included. Analyses were conducted on available outcome data from 32–38 patients. All were treated with a multidisciplinary DIT program for 6 months in a specialized care facility. Patients were followed up during treatment with the questionnaires Mental Health Continuum Short Form (MHC-SF) and Multidimensional Assessment of Interoceptive Awareness (MAIA) at baseline, 3 months and 6 months. Change was analysed with repeated measures ANOVA. The association between change in MAIA and change in MHC-SF was explored with linear regression analysis. Results: Both mental health (MHC-SF total score 28 to 33, p<0.001) and interoceptive awareness (MAIA score 88 to 92 p=0.045) increased after treatment. The improvement was mostly seen in the psychological and social wellbeing subscales of the MHC-SF and the self-regulation and body listening subscales of the MAIA. A higher pre- to post-treatment change on the MAIA was associated with a higher change on the MHC-SF (R2 = 0.352, B = 1.464, p < 0.001). Conclusions: This study shows that patients with PSS 1 have lower mental health scores relative to general population norm, 2) seem to have reduced capacity for interoceptive awareness 3) improve in both areas after completing DIT for PSS and 4) shows that improvement in interoceptive awareness was associated with improvement in mental health. Interoception based interventions in DIT-PSS might be a starting point for adequate treatment of PSS.
- 18 February 2026
- Published by Frontiers Media SA in Frontiers in Psychiatry
- Vol. 17
Open AccessImproving mental health through body-awareness with dynamic interpersonal therapy in patients with persistent somatic symptoms: an explorative cohort study
Introduction: This study explored the changes in mental health and body-awareness in patients with severe persistent somatic symptoms (PSS) treated with multidisciplinary Dynamic Interpersonal Therapy. Methods: In this longitudinal study 56 patients with severe somatic-symptom disorder (DSM-5) were included. Analyses were conducted on available outcome data from 32–38 patients. All were treated with a multidisciplinary DIT program for 6 months in a specialized care facility. Patients were followed up during treatment with the questionnaires Mental Health Continuum Short Form (MHC-SF) and Multidimensional Assessment of Interoceptive Awareness (MAIA) at baseline, 3 months and 6 months. Change was analysed with repeated measures ANOVA. The association between change in MAIA and change in MHC-SF was explored with linear regression analysis. Results: Both mental health (MHC-SF total score 28 to 33, p<0.001) and interoceptive awareness (MAIA score 88 to 92 p=0.045) increased after treatment. The improvement was mostly seen in the psychological and social wellbeing subscales of the MHC-SF and the self-regulation and body listening subscales of the MAIA. A higher pre- to post-treatment change on the MAIA was associated with a higher change on the MHC-SF (R2 = 0.352, B = 1.464, p < 0.001). Conclusions: This study shows that patients with PSS 1 have lower mental health scores relative to general population norm, 2) seem to have reduced capacity for interoceptive awareness 3) improve in both areas after completing DIT for PSS and 4) shows that improvement in interoceptive awareness was associated with improvement in mental health. Interoception based interventions in DIT-PSS might be a starting point for adequate treatment of PSS.
- Top Cited PapersOpen Access
- 14 January 2026
- Published by Royal College of Psychiatrists in BJPsych Open
- Vol. 12 (1) , e37
Systematic review on relapse-prevention strategies following successful electroconvulsive therapy for major depressive disorder
Background: Electroconvulsive therapy (ECT) is highly effective for major depressive disorder (MDD), but about 50% of patients relapse within 1 year. A comprehensive review of all potential relapse-prevention strategies is lacking. Aims: This systematic review aimed to identify, summarise and critically evaluate the available evidence on pharmacological, neuromodulatory, psychological and combination strategies to prevent relapse following successful ECT for MDD. Method: A systematic review was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines (PROSPERO: no. CRD42023392575). We searched PubMed, Embase, PsychInfo and Cochrane Library up to March 2025. Eligible studies included adults (>18 years) with unipolar MDD who responded to acute ECT and were followed for ≥3 months. We included randomised controlled trials (RCTs), cohort studies and case series (over ten cases). Risk of bias and quality were assessed and a narrative synthesis conducted. Results: A total of 28 studies ( N = 11 119) were included. Lithium (alone or with antidepressants) was most consistently associated with reduced relapse in 10 studies. Continuation ECT (C-ECT), particularly when combined with pharmacotherapy, also reduced relapse in several RCTs. Evidence for psychotherapy (e.g. cognitive–behavioural therapy) is limited (two studies), warranting further studies. No studies on repetitive transcranial magnetic stimulation or ketamine were found. Study quality varied, with some being underpowered or having used inconsistent definitions of relapse. Conclusions: Pharmacotherapy with lithium and, separately, C-ECT combined with medication, showed the strongest evidence for relapse prevention following ECT. The evidence base is limited by heterogeneity, small sample sizes and few studies on novel or psychological strategies. More robust clinical studies are needed to identify optimal long-term strategies.
- 14 January 2026
- Published by Royal College of Psychiatrists in BJPsych Open
- Vol. 12 (1) , e37
Top Cited PapersOpen AccessSystematic review on relapse-prevention strategies following successful electroconvulsive therapy for major depressive disorder
Background: Electroconvulsive therapy (ECT) is highly effective for major depressive disorder (MDD), but about 50% of patients relapse within 1 year. A comprehensive review of all potential relapse-prevention strategies is lacking. Aims: This systematic review aimed to identify, summarise and critically evaluate the available evidence on pharmacological, neuromodulatory, psychological and combination strategies to prevent relapse following successful ECT for MDD. Method: A systematic review was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines (PROSPERO: no. CRD42023392575). We searched PubMed, Embase, PsychInfo and Cochrane Library up to March 2025. Eligible studies included adults (>18 years) with unipolar MDD who responded to acute ECT and were followed for ≥3 months. We included randomised controlled trials (RCTs), cohort studies and case series (over ten cases). Risk of bias and quality were assessed and a narrative synthesis conducted. Results: A total of 28 studies ( N = 11 119) were included. Lithium (alone or with antidepressants) was most consistently associated with reduced relapse in 10 studies. Continuation ECT (C-ECT), particularly when combined with pharmacotherapy, also reduced relapse in several RCTs. Evidence for psychotherapy (e.g. cognitive–behavioural therapy) is limited (two studies), warranting further studies. No studies on repetitive transcranial magnetic stimulation or ketamine were found. Study quality varied, with some being underpowered or having used inconsistent definitions of relapse. Conclusions: Pharmacotherapy with lithium and, separately, C-ECT combined with medication, showed the strongest evidence for relapse prevention following ECT. The evidence base is limited by heterogeneity, small sample sizes and few studies on novel or psychological strategies. More robust clinical studies are needed to identify optimal long-term strategies.
- Open Access
- 2 October 2025
- Published by Taylor & Francis in Psychoanalytic Psychotherapy
- Vol. 39 (4) , 276-299
Understanding how group-based multidisciplinary dynamic interpersonal therapy works for severe somatic symptom disorder: a qualitative study of patient experiences
- 2 October 2025
- Published by Taylor & Francis in Psychoanalytic Psychotherapy
- Vol. 39 (4) , 276-299
Open AccessUnderstanding how group-based multidisciplinary dynamic interpersonal therapy works for severe somatic symptom disorder: a qualitative study of patient experiences
- 5 August 2025
- Vol. 169
[Inpatient treatment for refractory PSS].
Persistent somatic symptoms (PSS) is an umbrella term for physical symptoms lasting several months that limit daily functioning or cause significant distress, regardless of their etiology. Treatment can be effective, but in refractory PSS, which is often accompanied by severe functional impairments, treatment may fail or even have adverse effects. In clinical practice, inpatient admission is often considered in such cases. Two case studies illustrate the challenges and outcomes of inpatient treatment for refractory PSS. Patient A benefited from a structured and planned biopsychosocial approach, which led to improved functioning and reduced suicidality. In contrast, Patient B had a negative experience due to the absence of jointly established expectations and disappointment with the diagnostic procedures. These cases highlight the importance of a well-prepared admission process, in which the patient, relatives, and involved healthcare professionals discuss expectations and reach agreement on concrete goals to enable an effective start to the recovery process.
- 5 August 2025
- Vol. 169
[Inpatient treatment for refractory PSS].
Persistent somatic symptoms (PSS) is an umbrella term for physical symptoms lasting several months that limit daily functioning or cause significant distress, regardless of their etiology. Treatment can be effective, but in refractory PSS, which is often accompanied by severe functional impairments, treatment may fail or even have adverse effects. In clinical practice, inpatient admission is often considered in such cases. Two case studies illustrate the challenges and outcomes of inpatient treatment for refractory PSS. Patient A benefited from a structured and planned biopsychosocial approach, which led to improved functioning and reduced suicidality. In contrast, Patient B had a negative experience due to the absence of jointly established expectations and disappointment with the diagnostic procedures. These cases highlight the importance of a well-prepared admission process, in which the patient, relatives, and involved healthcare professionals discuss expectations and reach agreement on concrete goals to enable an effective start to the recovery process.
- 17 February 2025
- Published by Wolters Kluwer Health in The Journal of ECT
- Vol. 41 (3) , 197-205
Exploring the Decision-Making Process for Electroconvulsive Therapy in Patients With Major Depressive Disorder and Their Relatives After Treatment
Objectives: Shared decision making is used for reaching medical decisions, also in the management of major depressive disorder (MDD). Electroconvulsive therapy (ECT) is an effective treatment option for patients with severe MDD. However, the decision-making process, specifically the exchange of evidence-based information, for ECT may be hampered by the controversy and stigma surrounding ECT. We aim to explore the experiences of the decision-making process of patients and their relatives who have chosen to receive ECT in order to guide optimization of shared decision making in ECT. Methods: Semistructured interviews were conducted with MDD patients and their relatives who had voluntarily received ECT between 2018–2023 at the Radboud University Medical Center, the Netherlands. The interviews were analyzed by thematic analysis. Results: Meaning saturation occurred after 16 interviews. The following 3 major themes emerged: 1) information is key, 2) empowering the decision, and 3) lived experiences with ECT. Participants emphasized the importance of accessible information presented in a calm and stepwise manner. They also identified gaps in desired information, particularly regarding memory loss and difficulty in retaining the given information. Factors empowering the decision included support from family, healthcare professionals, peers, and desperation, while negative factors included stigma, negative images, lack of support, and fear. Lived experiences with ECT might influence a future decision. Positive experiences were improved attitudes, treatment effects, and empathic and involved professionals, while negative aspects included cognitive side effects and lack of follow-up. Conclusions: This study offers insights into factors influencing the decision-making process in patients with MDD that received ECT. It shows possibilities for improving the decision-making process in clinical practice.
- 17 February 2025
- Published by Wolters Kluwer Health in The Journal of ECT
- Vol. 41 (3) , 197-205
Exploring the Decision-Making Process for Electroconvulsive Therapy in Patients With Major Depressive Disorder and Their Relatives After Treatment
Objectives: Shared decision making is used for reaching medical decisions, also in the management of major depressive disorder (MDD). Electroconvulsive therapy (ECT) is an effective treatment option for patients with severe MDD. However, the decision-making process, specifically the exchange of evidence-based information, for ECT may be hampered by the controversy and stigma surrounding ECT. We aim to explore the experiences of the decision-making process of patients and their relatives who have chosen to receive ECT in order to guide optimization of shared decision making in ECT. Methods: Semistructured interviews were conducted with MDD patients and their relatives who had voluntarily received ECT between 2018–2023 at the Radboud University Medical Center, the Netherlands. The interviews were analyzed by thematic analysis. Results: Meaning saturation occurred after 16 interviews. The following 3 major themes emerged: 1) information is key, 2) empowering the decision, and 3) lived experiences with ECT. Participants emphasized the importance of accessible information presented in a calm and stepwise manner. They also identified gaps in desired information, particularly regarding memory loss and difficulty in retaining the given information. Factors empowering the decision included support from family, healthcare professionals, peers, and desperation, while negative factors included stigma, negative images, lack of support, and fear. Lived experiences with ECT might influence a future decision. Positive experiences were improved attitudes, treatment effects, and empathic and involved professionals, while negative aspects included cognitive side effects and lack of follow-up. Conclusions: This study offers insights into factors influencing the decision-making process in patients with MDD that received ECT. It shows possibilities for improving the decision-making process in clinical practice.
- Open Access
- 5 April 2023
- Published by Wiley in Acta Psychiatrica Scandinavica
- Vol. 147 (6) , 570-580
The impact of treatment resistance on outcome and course of electroconvulsive therapy in major depressive disorder
Introduction: Major depressive disorder (MDD) is a common psychiatric disorder. Despite several treatment options, a subgroup of patients will not respond to the commonly used antidepressant treatments and thus express treatment resistance (TRD). TRD can be quantified with the Dutch Measure for Treatment Resistance in Depression (DM‐TRD). Electroconvulsive therapy (ECT) is an effective treatment for MDD, also in TRD. Yet, the position of ECT as “treatment‐of‐last‐resort” may decrease the likelihood of beneficial outcome. Our aim was to investigate the association between treatment resistance and outcome and course of ECT.Methods: We performed a retrospective, multicenter cohort study with 440 patients of which data was retrieved from patient records as collected in the Dutch ECT Cohort database. Linear and logistic regression models were used to explore the association between level of treatment resistance and outcome of ECT. Median split was used to explore the differences between high and low level of TRD and course of treatment.Results: A higher DM‐TRD score was associated with significantly smaller reduction of depression symptoms (R2 = 0.160; β = −2.968; p < 0.001) and lower chance of response (OR = 0.821 [95 CI: 0.760–0.888]; β = −0.197; p < 0.001). Low level TRD patients underwent fewer ECT sessions (mean 13 ± 6 SD vs. 16 ± 7 SD; p < 0.001) and fewer switches from right unilateral tot bifrontotemporal electrode placement (29% vs. 40%; p = 0.032).Conclusion: Reserving ECT as “treatment‐of‐last‐resort” in the treatment algorithm for MDD seems questionable, because in our study lower level of treatment resistance predicted more beneficial ECT‐outcome. Moreover, providing ECT in less treatment resistant patients showed fewer needed ECT‐sessions and less switches to BL electrode placement, which may decrease the risk for cognitive side‐effects.
- 5 April 2023
- Published by Wiley in Acta Psychiatrica Scandinavica
- Vol. 147 (6) , 570-580
Open AccessThe impact of treatment resistance on outcome and course of electroconvulsive therapy in major depressive disorder
Introduction: Major depressive disorder (MDD) is a common psychiatric disorder. Despite several treatment options, a subgroup of patients will not respond to the commonly used antidepressant treatments and thus express treatment resistance (TRD). TRD can be quantified with the Dutch Measure for Treatment Resistance in Depression (DM‐TRD). Electroconvulsive therapy (ECT) is an effective treatment for MDD, also in TRD. Yet, the position of ECT as “treatment‐of‐last‐resort” may decrease the likelihood of beneficial outcome. Our aim was to investigate the association between treatment resistance and outcome and course of ECT.Methods: We performed a retrospective, multicenter cohort study with 440 patients of which data was retrieved from patient records as collected in the Dutch ECT Cohort database. Linear and logistic regression models were used to explore the association between level of treatment resistance and outcome of ECT. Median split was used to explore the differences between high and low level of TRD and course of treatment.Results: A higher DM‐TRD score was associated with significantly smaller reduction of depression symptoms (R2 = 0.160; β = −2.968; p < 0.001) and lower chance of response (OR = 0.821 [95 CI: 0.760–0.888]; β = −0.197; p < 0.001). Low level TRD patients underwent fewer ECT sessions (mean 13 ± 6 SD vs. 16 ± 7 SD; p < 0.001) and fewer switches from right unilateral tot bifrontotemporal electrode placement (29% vs. 40%; p = 0.032).Conclusion: Reserving ECT as “treatment‐of‐last‐resort” in the treatment algorithm for MDD seems questionable, because in our study lower level of treatment resistance predicted more beneficial ECT‐outcome. Moreover, providing ECT in less treatment resistant patients showed fewer needed ECT‐sessions and less switches to BL electrode placement, which may decrease the risk for cognitive side‐effects.
- Open Access
- 1 December 2020
- Published by Springer Nature in Antimicrobial Resistance & Infection Control
- Vol. 9 (1) , 1-8
Why psychiatry is different - challenges and difficulties in managing a nosocomial outbreak of coronavirus disease (COVID-19) in hospital care
Objective: Coronavirus disease (COVID-19) was officially declared a pandemic in March 2020. Many cases of COVID-19 are nosocomial, but to the best of our knowledge, no nosocomial outbreaks on psychiatric departments of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been reported in Europe. The different nature of psychiatry makes outbreak management more difficult. This study determines which psychiatry specific factors contributed to a nosocomial outbreak taking place in a psychiatric department. This will provide possible interventions in future outbreak management. Method: A case series describing a nosocomial outbreak in a psychiatric department of an acute care hospital in the Netherlands between March 13, 2020 and April, 14 2020. The outbreak was analyzed by combining data from standardized interviews, polymerase chain reaction (PCR) tests and whole genome sequencing (WGS). Results: The nosocomial outbreak in which 43% of staff of the psychiatric department and 19% of admitted patients were involved, was caused by healthcare worker (HCW)-to-HCW transmissions, as well as patient-to-HCW-to-patient transmission. We identified four aspects associated with the mental health care system which might have made our department more susceptible to an outbreak. Conclusions: Infection control measures designed for hospitals are not directly applicable to psychiatric departments. Psychiatric patients should be considered a high-risk group for infectious diseases and customized measures should be designed and implemented. Extra attention for psychiatric departments is necessary during a pandemic as psychiatric HCWs are less familiar with outbreak management. Clear communication and governance is crucial in correctly implementing these measures.
- 1 December 2020
- Published by Springer Nature in Antimicrobial Resistance & Infection Control
- Vol. 9 (1) , 1-8
Open AccessWhy psychiatry is different - challenges and difficulties in managing a nosocomial outbreak of coronavirus disease (COVID-19) in hospital care
Objective: Coronavirus disease (COVID-19) was officially declared a pandemic in March 2020. Many cases of COVID-19 are nosocomial, but to the best of our knowledge, no nosocomial outbreaks on psychiatric departments of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been reported in Europe. The different nature of psychiatry makes outbreak management more difficult. This study determines which psychiatry specific factors contributed to a nosocomial outbreak taking place in a psychiatric department. This will provide possible interventions in future outbreak management. Method: A case series describing a nosocomial outbreak in a psychiatric department of an acute care hospital in the Netherlands between March 13, 2020 and April, 14 2020. The outbreak was analyzed by combining data from standardized interviews, polymerase chain reaction (PCR) tests and whole genome sequencing (WGS). Results: The nosocomial outbreak in which 43% of staff of the psychiatric department and 19% of admitted patients were involved, was caused by healthcare worker (HCW)-to-HCW transmissions, as well as patient-to-HCW-to-patient transmission. We identified four aspects associated with the mental health care system which might have made our department more susceptible to an outbreak. Conclusions: Infection control measures designed for hospitals are not directly applicable to psychiatric departments. Psychiatric patients should be considered a high-risk group for infectious diseases and customized measures should be designed and implemented. Extra attention for psychiatric departments is necessary during a pandemic as psychiatric HCWs are less familiar with outbreak management. Clear communication and governance is crucial in correctly implementing these measures.
- Open Access
- 14 May 2019
- Published by Springer Nature in BMC Palliative Care
- Vol. 18 (1) , 40
Living at the end-of-life: experience of time of patients with cancer
The aim of this study was to gain insight into the experience of time of terminal patients with cancer. Experience of time is relevant in palliative care in both policy and practice. On a policy level, the Quality Adjusted Life Year (QALY), the most used outcome measure for cost-effectiveness analysis in healthcare, assumes time to be a linear and additive variable, which is one of the reasons that its applicability in palliative care is questioned. On a practice level, a better understanding of the experience of time of patients with limited time left, could help to recognize if and how these patients can have a more meaningful use of time. The main focus of this study was to discover whether time perception of these patients in their last months of life had changed as compared to earlier periods of time in their lives in good physical health. The pace of time and time dominance (comparison of past, present and future) were investigated. In several hospices and palliative care units in the Netherlands, twelve semi-structured interviews were conducted with terminal patients with cancer. Time perception at the end of life had changed for most participants. They all lived on a day-to-day basis in the terminal phase, independent of their way of life in the healthy phase. Furthermore, the experienced duration of a day turned out to be very different between patients, but also between days, depending on daily activities. Besides, for most patients for whom the future was the dominant period of time in the healthy phase, the dominant period of time in the terminal phase had become the past. Time perception of terminal patients with cancer differed from the time perception in their relatively healthy phase of life. This suggests that the LY part of the QALY is not comparable for all phases of life.
- 14 May 2019
- Published by Springer Nature in BMC Palliative Care
- Vol. 18 (1) , 40
Open AccessLiving at the end-of-life: experience of time of patients with cancer
The aim of this study was to gain insight into the experience of time of terminal patients with cancer. Experience of time is relevant in palliative care in both policy and practice. On a policy level, the Quality Adjusted Life Year (QALY), the most used outcome measure for cost-effectiveness analysis in healthcare, assumes time to be a linear and additive variable, which is one of the reasons that its applicability in palliative care is questioned. On a practice level, a better understanding of the experience of time of patients with limited time left, could help to recognize if and how these patients can have a more meaningful use of time. The main focus of this study was to discover whether time perception of these patients in their last months of life had changed as compared to earlier periods of time in their lives in good physical health. The pace of time and time dominance (comparison of past, present and future) were investigated. In several hospices and palliative care units in the Netherlands, twelve semi-structured interviews were conducted with terminal patients with cancer. Time perception at the end of life had changed for most participants. They all lived on a day-to-day basis in the terminal phase, independent of their way of life in the healthy phase. Furthermore, the experienced duration of a day turned out to be very different between patients, but also between days, depending on daily activities. Besides, for most patients for whom the future was the dominant period of time in the healthy phase, the dominant period of time in the terminal phase had become the past. Time perception of terminal patients with cancer differed from the time perception in their relatively healthy phase of life. This suggests that the LY part of the QALY is not comparable for all phases of life.